These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9546423)

  • 1. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
    Am J Trop Med Hyg; 1998 Mar; 58(3):378-85. PubMed ID: 9546423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.
    Valero MV; Amador LR; Galindo C; Figueroa J; Bello MS; Murillo LA; Mora AL; Patarroyo G; Rocha CL; Rojas M
    Lancet; 1993 Mar; 341(8847):705-10. PubMed ID: 8095622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
    Noya O; Gabaldón Berti Y; Alarcón de Noya B; Borges R; Zerpa N; Urbáez JD; Madonna A; Garrido E; Jimenéz MA; Borges RE
    J Infect Dis; 1994 Aug; 170(2):396-402. PubMed ID: 8035026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
    Alonso PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos de Azevedo I; Chongela J; Kobero S; Menendez C
    Lancet; 1994 Oct; 344(8931):1175-81. PubMed ID: 7934537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.
    Valero MV; Amador R; Aponte JJ; Narvaez A; Galindo C; Silva Y; Rosas J; Guzman F; Patarroyo ME
    Vaccine; 1996 Oct; 14(15):1466-70. PubMed ID: 8994323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F; Luxemburger C; Kyle DE; Ballou WR; Wittes J; Wah E; Chongsuphajaisiddhi T; Gordon DM; White NJ; Sadoff JC; Heppner DG
    Lancet; 1996 Sep; 348(9029):701-7. PubMed ID: 8806288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador.
    Sempértegui F; Estrella B; Moscoso J; Piedrahita L; Hernández D; Gaybor J; Naranjo P; Mancero O; Arias S; Bernal R
    Vaccine; 1994 Mar; 12(4):337-42. PubMed ID: 8178556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM; Acosta CJ; Schellenberg D; Aponte JJ; Roca A; Oettli A; Urassa H; Armstrong Schellenberg J; Kahigwa E; Ascaso C; Mshinda H; Lwilla F; Vidal J; Menendez C; Tanner M; Alonso PL
    Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
    Acosta CJ; Galindo CM; Schellenberg D; Aponte JJ; Kahigwa E; Urassa H; Schellenberg JR; Masanja H; Hayes R; Kitua AY; Lwilla F; Mshinda H; Menendez C; Tanner M; Alonso PL
    Trop Med Int Health; 1999 May; 4(5):368-76. PubMed ID: 10402973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination.
    Vitor-Silva S; Siqueira AM; de Souza Sampaio V; Guinovart C; Reyes-Lecca RC; de Melo GC; Monteiro WM; Del Portillo HA; Alonso P; Bassat Q; Lacerda MV
    Malar J; 2016 May; 15(1):266. PubMed ID: 27165432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for preventing malaria (SPf66).
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD005966. PubMed ID: 16625647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficacy trial of a malaria vaccine in Gambian infants and comparison with insecticide-treated bednets.
    D'Alessandro U
    Ann Trop Med Parasitol; 1996 Aug; 90(4):373-8. PubMed ID: 8944081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia.
    Taylor WR; Richie TL; Fryauff DJ; Picarima H; Ohrt C; Tang D; Braitman D; Murphy GS; Widjaja H; Tjitra E; Ganjar A; Jones TR; Basri H; Berman J
    Clin Infect Dis; 1999 Jan; 28(1):74-81. PubMed ID: 10028075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.